What is the emergency treatment for Stevens-Johnson Syndrome (SJS)/Toxic Epidermal Necrolysis (TEN) secondary to lamotrigine (Lamictal)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Emergency Treatment for Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Secondary to Lamotrigine

Patients with SJS/TEN secondary to lamotrigine should be immediately transferred to a burn center or ICU with experience treating SJS/TEN and facilities to manage extensive skin loss wound care. 1

Immediate Actions

  • Discontinue lamotrigine immediately as it is one of the most common drugs causing SJS/TEN 1, 2
  • Calculate SCORTEN within the first 24 hours of admission to predict mortality risk 1
  • Transfer patients with >10% body surface area (BSA) epidermal detachment to a specialized burn unit or ICU 1
  • Establish peripheral venous access through non-lesional skin for fluid resuscitation 1, 2
  • Arrange ophthalmology consultation within 24 hours of diagnosis to prevent permanent visual impairment 2, 3

Fluid Management

  • Monitor fluid balance carefully and catheterize if clinically indicated 1
  • Establish adequate intravenous fluid replacement guided by urine output and other end-point measurements 1
  • Avoid overaggressive fluid resuscitation which may cause pulmonary, cutaneous, and intestinal edema 1
  • Consider using the formula: body weight/% BSA epidermal detachment to determine replacement volumes 1

Wound Care

  • Handle skin carefully to minimize shearing forces and further epidermal detachment 1
  • Regularly cleanse wounds by gently irrigating with warmed sterile water, saline, or chlorhexidine (1/5000) 1
  • Apply greasy emollient (50% white soft paraffin with 50% liquid paraffin) over the whole epidermis, including denuded areas 1
  • Consider aerosolized formulations to minimize shearing forces associated with topical applications 1
  • Apply nonadherent dressings (such as Mepitel™ or Telfa™) to denuded dermis 1
  • Use secondary foam or burn dressings to collect exudate 1
  • Take swabs for bacterial and candidal culture from lesional skin, particularly sloughy areas 1

Pain Management

  • Use validated pain assessment tools at least once daily 1
  • Administer adequate analgesia using intravenous opioid infusions for those not tolerating oral medication 1
  • Consider patient-controlled analgesia where appropriate 1
  • Consider sedation or general anesthesia for patient handling, repositioning, and dressing changes 1

Infection Prevention and Management

  • Monitor for signs of systemic infection (confusion, hypotension, reduced urine output, reduced oxygen saturation) 1
  • Do not administer prophylactic systemic antibiotics as this may increase skin colonization, particularly with Candida albicans 1
  • Only institute antimicrobial therapy if there are clinical signs of infection 1
  • Watch for monoculture of organisms on culture swabs from multiple sites, which indicates increased likelihood of invasive infection 1

Systemic Treatment Options

  • Consider intravenous methylprednisolone for severe SJS/TEN, as it is FDA-approved for severe erythema multiforme (Stevens-Johnson syndrome) 4
  • When administering high-dose methylprednisolone (30 mg/kg), infuse over at least 30 minutes and repeat every 4-6 hours for 48 hours if needed 4
  • Other potential treatments include cyclosporine A and intravenous immunoglobulins, though evidence is less established 5, 6

Multidisciplinary Approach

  • Coordinate care through a multidisciplinary team led by a specialist in skin failure (dermatology/plastic surgery) 1
  • Include clinicians from intensive care, ophthalmology, and specialist skincare nursing 1
  • Consider additional input from respiratory medicine, gastroenterology, gynaecology, urology, oral medicine, microbiology, pain team, dietetics, physiotherapy, and pharmacy as needed 1

Environmental Considerations

  • Place patient in a side room controlled for humidity 1
  • Use a pressure-relieving mattress 1
  • Raise ambient temperature to between 25°C and 28°C 1

Common Pitfalls to Avoid

  • Delayed transfer to a specialized unit increases mortality risk 1
  • Overaggressive fluid resuscitation can cause complications 1
  • Indiscriminate use of prophylactic antibiotics may increase skin colonization 1
  • Neglecting eye care may result in permanent visual impairment 2, 3
  • Failure to recognize and treat sepsis, which is the most common cause of death in SJS/TEN 1, 7

Early recognition, immediate discontinuation of lamotrigine, and prompt transfer to a specialized unit with multidisciplinary care are crucial for improving survival and reducing long-term complications in patients with SJS/TEN.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.

Clinical reviews in allergy & immunology, 2018

Research

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: An Update.

American journal of clinical dermatology, 2015

Research

Toxic epidermal necrolysis and Stevens-Johnson syndrome.

Orphanet journal of rare diseases, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.